AAAAAA

   
Results: 1-3 |
Results: 3
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia
Authors: Ragni, MV Lusher, JM Koerper, MA Manco-Johnson, M Krause, DS
Citation: Mv. Ragni et al., Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia, HAEMOPHILIA, 6(2), 2000, pp. 98-103
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk
Authors: Thorland, EC Drost, JB Lusher, JM Warrier, I Shapiro, A Koerper, MA Dimichele, D Westman, J Key, NS Sommer, SS
Citation: Ec. Thorland et al., Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk, HAEMOPHILIA, 5(2), 1999, pp. 101-105
Germline origins in the human F9 gene: frequent G : C--> A : T mosaicism and increased mutations with advanced maternal age
Authors: Ketterling, RP Vielhaber, E Li, XM Drost, J Schaid, DJ Kasper, CK Phillips, JA Koerper, MA Kim, H Sexauer, C Gruppo, R Ambriz, R Paredes, R Sommer, SS
Citation: Rp. Ketterling et al., Germline origins in the human F9 gene: frequent G : C--> A : T mosaicism and increased mutations with advanced maternal age, HUM GENET, 105(6), 1999, pp. 629-640
Risultati: 1-3 |